93 related articles for article (PubMed ID: 11479227)
1. Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.
Medico E; Gentile A; Lo Celso C; Williams TA; Gambarotta G; Trusolino L; Comoglio PM
Cancer Res; 2001 Aug; 61(15):5861-8. PubMed ID: 11479227
[TBL] [Abstract][Full Text] [Related]
2. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
4. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.
Zohar R; Suzuki N; Suzuki K; Arora P; Glogauer M; McCulloch CA; Sodek J
J Cell Physiol; 2000 Jul; 184(1):118-30. PubMed ID: 10825241
[TBL] [Abstract][Full Text] [Related]
5. HGF and M-CSF modulate adhesion of MDA-231 breast cancer cell by increasing osteopontin secretion.
Grano M; Mori G; Minielli V; Colucci S; Vaira S; Giannelli G; Martemucci S; Giorgino F; Zallone AZ
J Biol Regul Homeost Agents; 2002; 16(3):190-5. PubMed ID: 12456016
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
Recio JA; Merlino G
Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
[TBL] [Abstract][Full Text] [Related]
7. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP
Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113
[TBL] [Abstract][Full Text] [Related]
8. Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
Castellone MD; Celetti A; Guarino V; Cirafici AM; Basolo F; Giannini R; Medico E; Kruhoffer M; Orntoft TF; Curcio F; Fusco A; Melillo RM; Santoro M
Oncogene; 2004 Mar; 23(12):2188-96. PubMed ID: 14981541
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin: possible role in prostate cancer progression.
Thalmann GN; Sikes RA; Devoll RE; Kiefer JA; Markwalder R; Klima I; Farach-Carson CM; Studer UE; Chung LW
Clin Cancer Res; 1999 Aug; 5(8):2271-7. PubMed ID: 10473115
[TBL] [Abstract][Full Text] [Related]
10. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
11. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS
Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703
[TBL] [Abstract][Full Text] [Related]
12. The role of Osteopontin in tumor metastasis.
Wai PY; Kuo PC
J Surg Res; 2004 Oct; 121(2):228-41. PubMed ID: 15501463
[TBL] [Abstract][Full Text] [Related]
13. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
Zhang KX; Ward KR; Schrader JW
Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
[TBL] [Abstract][Full Text] [Related]
14. Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulation.
Pañeda C; Gorospe I; Herrera B; Nakamura T; Fabregat I; Varela-Nieto I
Hepatology; 2002 Jun; 35(6):1381-91. PubMed ID: 12029623
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
Recio JA; Merlino G
Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
Zhu Y; Denhardt DT; Cao H; Sutphin PD; Koong AC; Giaccia AJ; Le QT
Oncogene; 2005 Sep; 24(43):6555-63. PubMed ID: 16007184
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
Liu YN; Kang BB; Chen JH
Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
[TBL] [Abstract][Full Text] [Related]
19. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.
Xu G; Nie H; Li N; Zheng W; Zhang D; Feng G; Ni L; Xu R; Hong J; Zhang JZ
J Clin Invest; 2005 Apr; 115(4):1060-7. PubMed ID: 15761492
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin.
Zhu B; Suzuki K; Goldberg HA; Rittling SR; Denhardt DT; McCulloch CA; Sodek J
J Cell Physiol; 2004 Jan; 198(1):155-67. PubMed ID: 14584055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
